Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396
July 03, 2023 06:01 ET
|
Zealand Pharma
Company announcement – No. 27 / 2023 Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396 Doses of 0.6 and 1.2 mg ZP8396...
Global Peptide Therapeutics Market on the Rise with Advancements in Biotechnology and Increased Demand for Targeted Therapies
June 12, 2023 21:30 ET
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, June 12, 2023 (GLOBE NEWSWIRE) -- The peptide therapeutics market is expanding due to the rising prevalence of some metabolic disorders such as genetic disorders, organ dysfunction...
Peptide Therapeutics Market Size to Hit USD 91.25 Bn by 2031 | TMR Study
April 14, 2023 15:00 ET
|
Transparency Market Research
Wilmington, Delaware, United States, April 15, 2023 (GLOBE NEWSWIRE) -- The worldwide market for peptide therapeutics is forecasted to augment at a CAGR of 8.8% from 2022 to 2031. According to...
MBX Biosciences to Participate in the SVB Securities Global Biopharma Conference
January 24, 2023 08:00 ET
|
MBX Biosciences, Inc.
CARMEL, Ind., Jan. 24, 2023 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptide™ (PEP™) therapeutics to treat an array of...
MBX Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 05, 2023 08:00 ET
|
MBX Biosciences, Inc.
CARMEL, Ind., Jan. 05, 2023 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptide™ (PEP™) therapeutics to treat an array of...
MBX Biosciences Closes $115 Million Series B Financing to Advance Development of Endocrine Disease Programs
November 14, 2022 08:00 ET
|
MBX Biosciences, Inc.
CARMEL, Ind., Nov. 14, 2022 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptide™ (PEP™) therapeutics to treat an array of...
Zealand Pharma Announces Financial Results for the First Nine Months of 2022
November 10, 2022 09:00 ET
|
Zealand Pharma
Company announcement No. 51 / 2022 Zealand Pharma Announces Financial Results for the First Nine Months of 2022 Copenhagen, Denmark November 10, 2022 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no....
MBX Biosciences Advances Phase 1 Clinical Trial of Long-Acting Parathyroid Hormone Peptide Prodrug, MBX 2109
October 05, 2022 09:00 ET
|
MBX Biosciences, Inc.
CARMEL, Ind., Oct. 05, 2022 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptide™ (PEP™) therapeutics to treat an array of...
Peptide Therapeutics Market Expanding at an Impressive CAGR of 11% over the period of 2022 to 2025 | Future Market Insights, Inc.
September 06, 2022 07:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Sept. 06, 2022 (GLOBE NEWSWIRE) -- The global peptide therapeutics market is projected to reach a valuation of US$ 47 Bn in 2025, with sales growing at a prolific CAGR of 11% from 2022...
Peptide Therapeutics Market is estimated to be US$ 66.18 billion by 2030 with a CAGR of 6.10% during the forecast period - By PMI
July 04, 2022 09:43 ET
|
PMI
Covina, July 04, 2022 (GLOBE NEWSWIRE) -- The joining of two or more amino acid monomers via amide bonds forms peptides. The size of a peptide is what separates it from a protein. Peptides are...